Insider · CIK 0001802653
Stephen Ray Mitchell
Files at VNDA (Vanda Pharmaceuticals Inc.). First filing Nov 18, 2024, latest Jun 16, 2025.
In brief
Stephen Ray Mitchell files SEC Form 4 as director at VNDA (Vanda Pharmaceuticals Inc.). Since Nov 18, 2024, Stephen Ray Mitchell has reported 0 open-market buys worth $0 and 2 open-market sells worth $58k, the latest filed on Jun 16, 2025.
A track record needs three past buys with six months of prices behind them; Stephen Ray Mitchell has 0, so none is measured yet.
The newest scored trade: sold $32k of VNDA on Jun 13, 2025, filed Jun 16, 2025, scored 20 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VNDA: Vanda Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | VNDAsell Vanda Pharmaceuticals Inc. | $32k 7,000 shares | -7% | +15% from low-17% from high | |
| 25Weak | VNDAsell Vanda Pharmaceuticals Inc. | $26k 5,000 shares | -10% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 13, 2025 | VNDA Vanda Pharmaceuticals Inc. | 7,000 0.01% of outstanding | $32k | Jun 13, 2025 | none |
| Nov 14, 2024 | VNDA Vanda Pharmaceuticals Inc. | 5,000 0.01% of outstanding | $27k | Nov 14, 2024 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | VNDA Vanda Pharmaceuticals Inc. | AGrant or award Common Stock | +41,600 | $0.00 | $0 | 112,846 | Jun 8, 2026 |
| May 18, 2026 | VNDA Vanda Pharmaceuticals Inc. | GGift Common Stock | -25,836 | $0.00 | $0 | 71,246 | May 20, 2026 |
| Jun 13, 2025 | VNDA Vanda Pharmaceuticals Inc. | SOpen-market sale Common Stock | -7,000 | $4.59 | $32k | 97,082 | Jun 16, 2025 |
| Jun 5, 2025 | VNDA Vanda Pharmaceuticals Inc. | AGrant or award Common Stock | +59,225 | $0.00 | $0 | 104,082 | Jun 9, 2025 |
| Nov 14, 2024 | VNDA Vanda Pharmaceuticals Inc. | SOpen-market sale Common Stock | -5,000 | $5.17 | $26k | 44,857 | Nov 18, 2024 |
Questions about Stephen Ray Mitchell
Answered from the filings on this page, as of the latest one.
Is Stephen Ray Mitchell buying or selling?
Not in the last 12 months. Stephen Ray Mitchell's latest open-market trade on SEC Form 4 was sold $32k of VNDA on Jun 13, 2025.
How did Stephen Ray Mitchell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen Ray Mitchell has 0.
Where does Stephen Ray Mitchell file Form 4?
Stephen Ray Mitchell has filed Form 4 at VNDA (Vanda Pharmaceuticals Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.